ALDEYRA 13G

Company

Aldeyra Therapeutics, Inc.

Filed

February 10, 2017

Accession Number

0001535264-17-000032

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →